PMC:7796052 / 471-643 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"15","span":{"begin":67,"end":77},"obj":"Gene"},{"id":"19","span":{"begin":91,"end":101},"obj":"Chemical"}],"attributes":[{"id":"A15","pred":"tao:has_database_id","subj":"15","obj":"Gene:3827"},{"id":"A19","pred":"tao:has_database_id","subj":"19","obj":"MESH:D020849"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In the scope of a drug repurposing campaign undertaken to identify bradykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process."}

{"project":"LitCovid-sentences","denotations":[{"id":"T5","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In the scope of a drug repurposing campaign undertaken to identify bradykinin antagonists, raloxifene was identified as prospective compound in a virtual screening process."}